Abstract:OBJECTIVES:To evaluate the value of thrombospond in Type I domain-containing 7A (THSD7A) and M-type phospholipase A2 receptor (PLA2R) in primary membranous nephropathy (PMN) and to explore the relationship between their antibody levels and prognosis.METHODS:Renal tissues in 128 patients with membranous nephropathy in the Second Xiangya Hospital of Central South University were collected from February 2015 to August 2017, including 108 patients with primary membranous nephropathy (PMN group) and 20 patients with secondary membranous nephropathy (SMN) (SMN group). Indirect immunofluorescence method was used to detect the expression of PLA2R antigen in kidney tissues,and the glomerular expression of THSD7A antigen was examined by immunohistochemistry and indirect immunofluorescence. The serum levels of anti-PLA2R antibodies and THSD7A antibodies were also detected by ELISA. According to the results of PMN examination,the patients were also divided into a PLA2R-related membranous nephropathy group and a THSD7A-related membranous nephropathy group.RESULTS:The positive rate of PLA2R in the renal tissues in the PMN group was higher than that in the SMN group (78% in the PMN group, 35% in the SMN group, P<0.01),while the positive rate of anti-PLA2R antibody in the PMN group was also higher than that in the SMN group (50% in the PMN group, 25% in the SMN group, P<0.05).The serum level of anti-PLA2R antibody was positively correlated with 24 h urine protein (r=0.254, P<0.05) and negatively correlated with serum albumin (r=-0.236, P<0.05). The expression of THSD7A was positive in glomeruli in 7 cases of the PMN group (6%) by immuno-histochemistry, and which was positive in 1case of the SMN group (5%).The serum levels of anti-THSD7A antibody in the PMN group were higher than those in the SMN group [(0.49±0.26) pg/mL in the PMN group,(0.34±0.27) pg/mL in the SMN group, P<0.05]. There was no difference in the clinical characteristics between the PLA2R-related membranous nephropathy group and the THSD7A-related membranous nephropathy group.CONCLUSIONS:PLA2R and THSD7A are the target antigen of PMN, and the associated autoantibodies are helpful for the differential diagnosis of PMN. The anti-PLA2R antibody levels can reflect the severity of the disease and evaluate the effect of treatment. The incidence of THSD7A membranous nephropathy is low, and monitoring the serum anti-THSD7A antibody levels can assess patients' condition and predict disease outcome.

The expression of M-type phospholipase A2 receptor and thrombospondin-type 1 domain con-taining 7A in idiopathic membranous nephropathy

[Diagnostic Value of Renal Phospholipase A2 Receptor and Serum Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy].

Quantitative Detection of Anti-Pla2r Antibodies Targeting Different Epitopes and Its Clinical Application in Primary Membranous Nephropathy.

Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China

Clinical Significance of M-type Phospholipase A2 Receptor and Thrombospondin Type 1 Domain-Containing 7A in Primary Membranous Nephropathy

A Novel Time-Resolved Fluoroimmunoassay Based on Magnetic Microspheres Method for Detecting Antibodies Against the Phospholipase A2 Receptor.

Detection of PLA2R1 in Renal Biopsy Specimens of Patients with Idiopathic Membranous Ne-Phropathy

Research progress of idiopathic membranous nephropathy associated antigen phospholipase A2 receptor and thrombospondin type-1 domain containing 7A

Detection And Clinical Significance Of Glomerular M-Type Phospholipase A(2) Receptor In Patients With Idiopathic Membranous Nephropathy

Urine PLA2R Antibody Detection in Hazard Stratification of PLA2R-Associated Membranous Nephropathy.

Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy

Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China

Serum Phospholipase A2 Receptor Antibodies and Immunoglobulin G Subtypes in Adult Idiopathic Membranous Nephropathy: Clinical Value Assessment.

M-Type Phospholipase A2 Receptor Autoantibody Measured by ELISA has Diagnostic Value in Patients with Idiopathic Membranous Nephropathy

Diagnostic value of serum PLA2R antibody detection for idiopathic membranous nephropathy: A meta-analysis

Biomarkers To Detect Membranous Nephropathy In Chinese Patients

Clinical Study of THSD7A, SOD2 and AR Antigens in Idiopathic Membranous Nephropathy

The significance of serum phospholipase A2 receptor antibody in remission of idiopathic membranous nephropathy

Anti-phospholipase A2 Receptor Antibody in Membranous Nephropathy.

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody As A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy

Circulating Antibodies Against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.